Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
用户ZD2Ry9-cWPa4
14天前
80
10
已完结
1. 系统已在2026-07-16 16:41:57对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
其他信息:
出版社: American Society of Hematology
作者: Yuqin Song; Qingqing Cai; Keshu Zhou; Zhengming Jin; Ming Jiang; Xiuhua Sun; Lei Zhang; Haiyan Yang; Lanfang Li; Kaiyang Ding; Junyuan Qi; MIN Zhou; Hongmei Jing; Wei Yang; Hui Zhou; Jun Ma; Zhigang Peng; Wei Xu; Li Yu; Yuankai Shi; Guohui Cui; Zheng Wang; Nawei Liu; Yejiang Lou; Yue Shen; Yi Chen; Fenlai Tan; Jun Zhu
全文下载地址: https://ashpublications.org/blood/article-pdf/146/Supplement 1/3896/2449753/blood-6643-main.pdf
